A new oral medication for T1D is awaiting FDA approval, and it’s shown fewer highs, fewer lows, and more predictable insulin dosing in recent studies.
[read_more text="read more" title="read more" url="https://tcoyd.org/2018/10/new-kids-on-the-block-oral-meds-for-type-1/" align="left"]